Benjamin E. Rich
Brigham and Women's Hospital
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Benjamin E. Rich.
PLOS ONE | 2009
Renata Mazzucchelli; Søren Warming; Scott M. Lawrence; Masaru Ishii; Mehrnoosh Abshari; A. Vallance Washington; Lionel Feigenbaum; Andrew C. Warner; Davis J. Sims; Wenqing Li; Julie A. Hixon; Daniel Gray; Benjamin E. Rich; Matthew P. Morrow; Miriam R. Anver; James Cherry; Dieter Naf; Lawrence R. Sternberg; Daniel W. McVicar; Andrew G. Farr; Ronald N. Germain; Keith Rogers; Nancy A. Jenkins; Neal G. Copeland; Scott K. Durum
Interleukin-7 (IL-7) is required for lymphocyte development and homeostasis although the actual sites of IL-7 production have never been clearly identified. We produced a bacterial artificial chromosome (BAC) transgenic mouse expressing ECFP in the Il7 locus. The construct lacked a signal peptide and ECFP (enhanced cyan fluorescent protein ) accumulated inside IL-7-producing stromal cells in thoracic thymus, cervical thymus and bone marrow. In thymus, an extensive reticular network of IL-7-containing processes extended from cortical and medullary epithelial cells, closely contacting thymocytes. Central memory CD8 T cells, which require IL-7 and home to bone marrow, physically associated with IL-7-producing cells as we demonstrate by intravital imaging.
Current Biology | 2001
Benjamin E. Rich; Thomas S. Kupper
The newly discovered cytokine interleukin-20 (IL-20) is structurally related to IL-10, yet it appears to be an autocrine factor for keratinocytes that regulates their participation in inflammation.
Journal of Immunology | 2009
Laura S. Bursch; Benjamin E. Rich; Kristin A. Hogquist
Langerhans cells (LC) are APC that reside at the barrier surfaces. Mice expressing an OVA peptide in the epidermis (K14-OVAp) were used to study CD8+ T cell responses to an epidermal self-Ag. Earlier results suggested that LC were the predominant APC, inducing a robust T cell response and autoimmunity. In this study, we used a whole protein model system, the K14-mOVA mouse, in which a transmembrane form of OVA was expressed in keratinocytes. In contrast to K14-OVAp mice, T cells in K14-mOVA mice were activated, but did not expand and instead died by apoptosis. Furthermore, in double-transgenic mice expressing both mOVA and OVAp, robust OT-I expansion occurred, indicating that tolerance to this Ag is not dominant and was due to lack of activating signals. We sought to identify the relevant APC in K14 mice using bone marrow chimeras and found that radioresistant cells (presumably LC) were able to cross-present the OVA Ag from keratinocytes to naive T cells in the lymph node. However, use of LC-deficient mice indicated that LC were not required for the expansion of OT-I in K14-OVAp or the deletion of OT-I in K14-mOVA mice. These data suggest that radioresistant non-LC present self-Ag in K14-OVAp mice and drive a robust CD8 T cell response.
Clinical Cancer Research | 2006
Keiichi Yamanaka; Rachael A. Clark; Rebecca Dowgiert; Daniel Hurwitz; Michio Shibata; Benjamin E. Rich; Kazuki Hirahara; David A. Jones; Sara Eapen; Hitoshi Mizutani; Thomas S. Kupper
Purpose: Cutaneous T-cell lymphoma (CTCL) is a malignancy of skin-homing Th2 T cells. Clonal T cells and CTCL skin lesions typically express Th2 cytokines, including interleukin (IL)-4, IL-5, and IL-10, but fail to produce Th1 cytokines. However, the reason for Th2 bias is unknown. IL-18 is a pleiotropic proinflammatory cytokine produced by monocytes/macrophages lineage as well as epithelial cells, such as human keratinocytes. In the absence of IL-12, IL-18 leads to increased immunoglobulin E production from B cells and enhanced production of IL-4 and IL-13 by basophils, mast cells, and CD4+ T cells. We have analyzed cytokines in CTCL patients, which may bias the immune response around the Th1/Th2 axis. Experimental Design: We examined plasma of 95 CTCL patients and skin of 20 CTCL patients for IL-18, caspase-1, IL-12, and other cytokines. To identify the presence or absence of these cytokine proteins in CTCL and normal skin, we cultured explants from skin biopsies on three-dimensional matrices. Results: Plasma levels of IL-18 and its converting enzyme, caspase-1, were significantly elevated in CTCL. mRNA levels for these factors were also elevated in CTCL skin lesions. Matrices populated with CTCL lesional skin produced significant amounts of IL-18 and caspase-1; however, production of IL-12 protein was barely detectable. Conclusions: We propose that the high levels of IL-18 expression in lesional CTCL skin contribute to increased plasma levels of IL-18 and that this, in the face of significantly lower levels of IL-12, may contribute to the Th2 bias seen in this disease.
Journal of Immunology | 2009
Teresa Bianchi; Laura B. Pincus; Marc-André Wurbel; Benjamin E. Rich; Thomas S. Kupper; Robert C. Fuhlbrigge; Marianne Boes
Immunological tolerance is crucial to avoid autoimmune and inflammatory diseases; however, the mechanisms involved are incompletely understood. To study peripheral tolerance to skin-associated Ags, we generated new transgenic mice expressing a membrane-bound form of OVA in skin under the human keratin 14 (K14) promoter (K14-mOVA mice). In contrast to other transgenic mice expressing similar self-Ags in skin, adoptive transfer of Ag-specific T cells does not induce inflammatory skin disease in our K14-mOVA mice. OVA-specific T cells transferred into K14-mOVA mice are activated in lymphoid tissues, undergo clonal expansion, and eventually acquire effector function. Importantly, these Ag-specific T cells selectively up-regulate expression of E-selectin ligand in cutaneous lymph nodes but not in mesenteric lymph nodes and spleen, demonstrating that expression of endogenous self-Ags in skin dictates imprinting of skin tissue homing in vivo. However, an additional inflammatory signal, here induced by tape stripping, is required in K14-mOVA mice to induce T cell migration to skin and development of inflammatory skin disease. Depletion of regulatory CD4+CD25+ T cells did not provoke homing of transferred T cells to skin under steady-state conditions, indicating that these cells are not the key regulators for inhibiting T cell homing in K14-mOVA mice. Both skin-derived and lymph node-resident CD8α+ dendritic cells are responsible for Ag presentation in vivo and induce tolerance to skin Ags, as we show by selective depletion of langerin+ and CD11c+ dendritic cells. Taken together, controlled skin homing of T cells is critical for the maintenance of peripheral immune tolerance to epidermal self-Ags.
Archive | 1997
Liming Liu; Benjamin E. Rich; Jun-ichi Inobe; Wunjun Chen; Howard L. Weiner
Differential cytokine production (Thl versus Th2) by CD4+ T cells during an immune response plays an important role in determining the biological implications of the response. Th1 cells are characterized by the dominance of IFN-γ production while Th2 cells produce predominantly 1L-4. It is now well established that IL-12 is essential for the priming of Thl cytokine secreting T cells1 while IL-4 is critical in the priming of Th2 cytokine secreting T cells2. While it has been suggested that CD1 specific NK1.1 CD4+ T cells in the spleen3, or CD4- CD8-, TCRαβ+ T cells restricted by MHC class I4 might be the potential sources of IL-4 during primary immune responses, these have not been clearly demonstrated.
Laboratory Investigation | 2018
Daniel Aires; Masaru Yoshida; Stephen K. Richardson; Mei Bai; Luzheng Liu; Roberto Moreno; Alexander J. Lazar; Jo Wick; Benjamin E. Rich; George F. Murphy; Richard S. Blumberg; Robert C. Fuhlbrigge; Thomas S. Kupper
Distinct populations of effector memory T cells use different homing receptors to traffic to the skin and gut. Whether tissue-selective T cells are needed for early rejection of a neoplasm growing in these tissues remains an open question. We chose to study an allogeneic tumor model because growth of such a fully mismatched tumor would signify a profound immune deficit. We implanted allogeneic tumor cells in the skin or gut of mice deficient in either α(1,3) fucosyltransferases IV and VII, enzymes critical for generating E-selectin ligands on skin-homing T cells, or β7 integrin, a component of the α4β7 integrin ligand for the mucosal adressin MAdCAM. During the first 9 days after tumor implantation, FucTVII−/− mice showed a profoundly impaired capacity to reject tumors growing in the skin, but readily rejected tumors implanted in the gut. Rejection of tumors in the skin was even more impaired in mice deficient in both FucTIV and FucTVII. This impairment was corrected by infusion of T cells from normal mice. By contrast, β7 integrin−/− mice showed profoundly impaired rejection of tumors in the gut, but no defect in the skin tumor rejection. These differences were unrelated to antigen recognition or effector function of T cells, since all strains of mice were capable of generating tumor-specific CTLs in vitro against the tumor cell line used in vivo. These results demonstrate that T-cell homing defects in vivo impair immune surveillance of peripheral epithelial tissues in a specific and selective fashion.Highly immunogenic tumors were implanted in mice deficient in either T cell skin homing molecules or T cell gut homing molecules. Rejection of tumors was deficient in skin or gut, respectively, but intact in unaffected tissues. The authors conclude that T cell trafficking plays an important and heretofore overlooked role in tumor immunity.
Blood | 2001
Onder Alpdogan; Cornelius Schmaltz; Stephanie J. Muriglan; Barry J. Kappel; Miguel-Angel Perales; Jimmy A. Rotolo; Jens A. Halm; Benjamin E. Rich; Marcel R.M. van den Brink
International Immunology | 1998
Liming Liu; Benjamin E. Rich; Jun-ichi Inobe; WanJun Chen; Howard L. Weiner
Journal of Immunology | 1997
Ifor R. Williams; E A Rawson; L Manning; T Karaoli; Benjamin E. Rich; Thomas S. Kupper